Cargando…

838. Drivers of empiric carbapenem use: How important is history of extended-spectrum beta-lactamase (ESBL) infection?

BACKGROUND: CARs are first line agents for serious infections caused by ESBL producers. Likelihood of developing subsequent ESBL infection is unknown. In patients (pts) with a history (hx) of ESBL positive (ESBLP) culture, empiric therapy with a CAR has become common in hospitals. The purpose of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stone, Tyler J, Beardsley, James, Johnson, James, Ohl, Christopher, Luther, Vera, Palavecino, Elizabeth, Williamson, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777261/ http://dx.doi.org/10.1093/ofid/ofaa439.1027

Ejemplares similares

Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?
por: Stone, Tyler J., et al.
Publicado: (2023)

118. Optimizing the management of coagulase-negative staphylococci (CoNS) contaminants by reporting the species name
por: Stone, Tyler J, et al.
Publicado: (2020)

607 Identification of Viral Infection Using a Polymerase Chain Reaction (PCR)-based Respiratory Virus Panel (RVP) Decreases Antibacterial Use
por: Rokas, Kristina, et al.
Publicado: (2014)

1877. Discrepant Susceptibilities Have Minimal Impact on Antibiotic Prescribing for Patients With Two or More Blood Cultures Positive for Coagulase-Negative Staphylococci
por: Smith, Jessica, et al.
Publicado: (2018)

2249. Impact of Minimum Inhibitory Concentration on Clinical Outcomes of Daptomycin for VRE Bloodstream Infection Among Neutropenic Oncology Patients
por: Caulder, Elisabeth, et al.
Publicado: (2019)

184. Impact of the BioFire® FilmArray® Blood Culture Identification 2 Panel on Antimicrobial Treatment of Enterobacterales Blood Stream Infections
por: Logan, Ashley, et al.
Publicado: (2022)

182. Piperacillin/tazobactam (P/T) versus meropenem (Mero) for treatment of extended-spectrum beta-lactamase (ESBL)-producing E.coli and K. pneumoniae bloodstream infections (BSIs)
por: Cox, Alexandra L, et al.
Publicado: (2023)

877. Synovial Fluid Testing Using the BioFire® Joint Infection (JI) Panel Potentially Decreases Time to Antibiotic Optimization for Acute Joint Infections
por: Whitt, Benjamin, et al.
Publicado: (2022)

1799. Impact of Real-Time Electronic Notifications to Pharmacists of Rapid Diagnostic Blood Culture Results
por: Caulder, Liz, et al.
Publicado: (2018)

Evaluation of the Potential Impact of a Multiplex Rapid Diagnostic Panel in Critically Ill Patients With Hospital-Acquired Pneumonia
por: Erich, Bradley J, et al.
Publicado: (2022)

1032. Evaluation of a Multiplex Rapid Diagnostic Panel in Respiratory Specimens from Critically Ill Patients with Hospital-Acquired Pneumonia
por: Erich, Bradley J, et al.
Publicado: (2021)

1267. Comparative activity of omadacycline against extended-spectrum beta-lactamase positive and negative Escherichia coli and Klebsiella pneumoniae strains recovered from urine specimens
por: Stone, Tyler J, et al.
Publicado: (2020)

A comparison of active versus passive methods of responding to rapid diagnostic blood culture results
por: Chandler, Elisabeth L., et al.
Publicado: (2022)

Clinical impact of a multiplex rapid diagnostic pneumonia panel in critically ill patients
por: Esplund, Jayda N., et al.
Publicado: (2023)

Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program
por: Liu, Peter, et al.
Publicado: (2016)

Collaborative Antimicrobial Stewardship: Working with Microbiology
por: Palavecino, Elizabeth L., et al.
Publicado: (2020)

The Impact of Diagnostic Stewardship on Clostridium difficile Infections
por: Bischoff, Werner, et al.
Publicado: (2017)

In Vitro Activity of Omadacycline and Comparator Antibiotics against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Urinary Isolates
por: Stone, Tyler J., et al.
Publicado: (2023)

333. Clinical Impact of a Multiplex Rapid Diagnostic Panel in Critically Ill Patients
por: Esplund, Jayda, et al.
Publicado: (2022)

Treatment of Candida nivariensis Blood Stream Infection With Oral Isavuconazole
por: Randazza, Olivia, et al.
Publicado: (2022)

1600. Closing the gap on moxifloxacin breakpoints for Stenotrophomonas maltophilia
por: Stone, Tyler J, et al.
Publicado: (2020)

Impact of a Stewardship Initiative to Decrease Treatment of Asymptomatic Bacteriuria and Pyuria in the Emergency Department
por: Smith, Jessica, et al.
Publicado: (2017)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

51. Sustained Impact of an Antimicrobial Stewardship (AS) Initiative Targeting Asymptomatic Bacteriuria and Pyuria in the Emergency Department (ED)
por: Cash, Mary Catherine, et al.
Publicado: (2021)

2223. Evaluation of the Microbiology and Clinical Outcomes of Spontaneous Bacterial Peritonitis (SBP) within a US Academic Health System
por: Chris Parish, P, et al.
Publicado: (2023)

Effective Photodynamic Therapy with Ir(III) for Virulent Clinical Isolates of Extended-Spectrum Beta-Lactamase Klebsiella pneumoniae
por: Núñez, Constanza, et al.
Publicado: (2021)

Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2022)

190. Promise and Pitfalls: Analyzing the Accuracy and Perceptions of Documenting Antibiotic Indication During Order Entry
por: Beardsley, James, et al.
Publicado: (2018)

Sustained impact of an antibiotic stewardship initiative targeting asymptomatic bacteriuria and pyuria in the emergency department
por: Cash, Mary Catherine, et al.
Publicado: (2022)

1199. Effectiveness of Non-carbapenem vs Carbapenems Empiric Therapy for Extended-Spectrum β-Lactamase (ESBL)-producing Enterobacterales (PE) Infections in Non-ICU patients: A Real-world Investigation in a Hospital with High-prevalence of ESBL-PE
por: Kang, Amy Y, et al.
Publicado: (2023)

Effective Treatment against ESBL-Producing Klebsiella pneumoniae through Synergism of the Photodynamic Activity of Re (I) Compounds with Beta-Lactams
por: González, Iván A., et al.
Publicado: (2021)

Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
por: Husna, Asmaul, et al.
Publicado: (2023)

2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems
por: John, Reeba, et al.
Publicado: (2018)

To Use, or Not to Use Carbapenem When Extended-spectrum β-lactamase (ESBL)-producing Bacteria Are Isolated from Sputum Cultures, That Is the Question
por: Miki, Makoto
Publicado: (2017)

479 Clinical outcomes in patients with extended-spectrum-beta-lactamase-producing (ESBL) Enterobacteriaceae bloodstream infections (ESB) treated with carbapenems (CP) and non-carbapenems (NC)
por: Chin, Judy, et al.
Publicado: (2014)

Extended-Spectrum β-Lactamases (ESBL) Producing Bacteria in Animals
por: Tseng, Chien-Hao, et al.
Publicado: (2023)

Moxalactam is not more active on extended spectrum β-lactamase (ESBL) producing bacteria than on non-ESBL producers
por: Singh, Bhoj R
Publicado: (2018)

Analysis of Extended Spectrum Beta Lactamase (ESBL) Genes of Non-Invasive ESBL Enterobacterales in Southeast Austria in 2017
por: Paulitsch-Fuchs, Astrid H., et al.
Publicado: (2022)

Assessment of well water as a reservoir for extended-spectrum β-lactamases (ESBL) and carbapenem resistant Enterobacteriaceae from Iwo, Osun state, Nigeria
por: Akinola, Omowumi Temitayo, et al.
Publicado: (2022)

Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
por: Ng, Tat Ming, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_umcabu7emaaqdcl26rvf7lejug